Results 11 to 20 of about 52,108 (298)
Thrombotic thrombocytopenic purpura. [PDF]
Nature Reviews Disease Primers, 2017 Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and organ ischemia linked to disseminated microvascular platelet rich-thrombi.
B. Joly, P. Coppo, A. Veyradier
semanticscholar +8 more sources
Thrombotic thrombocytopenic purpura [PDF]
The Journal of the American Osteopathic Association, 1989 Once formerly thought to be a rare disorder, thrombotic thrombocytopenic purpura (TTP) is becoming increasingly recognized. It is characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever.
Kevin C. McCormick
openalex +4 more sources
Thrombotic Thrombocytopenic Purpura
Journal of Associated Medical Sciences, 2015 -
Nuchanat Nonsee, Prasit Chanarat
doaj +4 more sources
Vaccination and Thrombotic Thrombocytopenic Purpura
Turkish Journal of Hematology, 2020 In the adult age group, vaccines did not contribute to the development of immune thrombocytopenia (ITP), but an increase was reported in diphtheria-tetanus-pertussis-poliomyelitis vaccines without statistical significance [2].
I. Yavaşoğlu
semanticscholar +5 more sources
Thrombotic thrombocytopenic purpura [PDF]
memo - Magazine of European Medical Oncology, 2018 Thrombotic thrombocytopenic purpura (TTP) is a clearly defined entity of the thrombotic microangiopathies (TMA), a heterogeneous group of disorders characterized by microangiopathic hemolytic anemia with red cell fragmentation, thrombocytopenia and organ dysfunction due to disturbed microcirculation.
Yaakov Beilin, Joshua Hamburger
openaire +5 more sources
Annual Incidence and Severity of Acute Episodes in Hereditary Thrombotic Thrombocytopenic Purpura.
Blood, 2021 Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare thrombotic microangiopathy characterized by severe congenital ADAMTS13 deficiency and recurring acute episodes causing morbidity and premature death.
E. Tarasco +17 more
semanticscholar +1 more source
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
International journal of hematology, 2021 Thrombotic thrombocytopenic purpura (TTP) is a known menace in hematology and is quite rare in practice with known triggers. Lately, in the COVID-19 pandemic, hematology has seen a new pathology amongst which TTP associated with COVID-19 messenger RNA ...
S. H. Waqar, A. Khan, S. Memon
semanticscholar +1 more source
Journal of International Medical Research, 2022 A 33-year-old Chinese woman with a history of immune thrombocytopenic purpura presented with heavy menstrual bleeding. She was found to have thrombocytopenia, plasma ADAMTS13 activity of 0%, and positivity for the plasma ADAMTS13 inhibitor.
Hangping Ge +7 more
doaj +1 more source
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite an increase in our understandings of pathogenesis of thrombotic thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of TTP vary significantly.
X. L. Zheng +13 more
semanticscholar +1 more source
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its appropriate treatment.
X. L. Zheng +13 more
semanticscholar +1 more source